Orthopedic device company Enovis recorded $565 million in net sales during the second quarter, according to an Aug. 7 news release from the company.
Here are five more financial notes to know:
- The company’s 2025 second quarter sales grew 7% on a reported basis and 5% on an organic basis compared to the second quarter in 2024.
- Enovis reported a second-quarter net loss of $37 million and adjusted EBITDA of $97 million.
- The company expects 2025 revenue to be between $2.22 and $2.25 billion, up slightly from previous projections.
- Through the first two quarters of 2025, Enovis has $1.12 billion in net sales, up from $1.04 billion in net sales through the first half of 2024.
- Enovis had a gross profit margin of 59.3% in the second quarter of 2025, compared to 55% in the second quarter of 2024.
